Neutrophil transintestinal epithelial migration to CXCR2 ligands is regulated by adenosine

Journal of Pediatric Gastroenterology and Nutrition

Volumn 54, Issue 3, 2012, Pages 414-421

  Stadnyk, Andrew W ^a   Carrigan, Svetlana O ^a   Otley, Anthony R ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

adenosine; colitis; CXCR; interleukin 8; neutrophil

Indexed keywords

ADENOSINE; ADENOSINE DEAMINASE; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; CXCL1 CHEMOKINE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; INTERLEUKIN 8; SUPEROXIDE;

ADOLESCENT; ADULT; ARTICLE; BLOOD; CHILD; CHRONIC GRANULOMATOUS DISEASE; COLON CARCINOMA; COLON MUCOSA; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTESTINE EPITHELIUM CELL; MONOLAYER CULTURE; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN BINDING; SCHOOL CHILD; TRANSCELLULAR CELL MIGRATION;

ADENOSINE; ADENOSINE DEAMINASE; ADOLESCENT; ADULT; ANTIGENS, CD18; CHEMOKINE CXCL1; CHEMOKINE CXCL5; CHEMOTAXIS, LEUKOCYTE; CHILD; COLONIC NEOPLASMS; EPITHELIAL CELLS; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-8; INTESTINAL MUCOSA; LIGANDS; MALE; NEUTROPHIL INFILTRATION; NEUTROPHILS; RECEPTORS, INTERLEUKIN-8B; YOUNG ADULT;

EID: 84857791474     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0b013e3182318d13     Document Type: Article

References (31)

1. Tibble JA, Bjarnason I. Fecal calprotectin as an index of intestinal inflammation. Drugs Today (Barc) 2001;37:85-96. (Pubitemid 32290286)
2. Kane SV, Sandborn WJ, Rufo PA, et al. Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation. Am J Gastroenterol 2003;98:1309-14. (Pubitemid 36741528)
3. Gouni-Berthold I, Baumeister B, Wegel E, et al. Neutrophil-elastase in chronic inflammatory bowel disease: a marker of disease activity? Hepatogastroenterology 1999;46:2315-20. (Pubitemid 29454091)
4. Fagerberg UL, Loof L, Myrdal U, et al. Colorectal inflammation is well predicted by fecal calprotectin in children with gastrointestinal symptoms. J Pediatr Gastroenterol Nutr 2005;40:450-5. (Pubitemid 40489572)
5. Madara JL, Patapoff TW, Gillece-Castro B, et al. 5′-adenosine monophosphate is the neutrophil-derived paracrine factor that elicits chloride secretion from T84 intestinal epithelial cell monolayers. J Clin Invest 1993;91:2320-5. (Pubitemid 23141512)
6. Stadnyk AW. Intestinal epithelial cells as a source of inflammatory cytokines and chemokines. Can J Gastroenterol 2002;16:241-6. (Pubitemid 34727590)
7. Brandt E, Mü ller-Alouf H, Desreumaux P, et al. Circulating growthregulated oncogene a contributes to neutrophil priming and interleukin-8-directed mucosal recruitment into chronic lesions of patients with Crohn's disease. Eur Cytokine Netw 1998;9:647-53. (Pubitemid 29033932)
8. Z'Graggen K, Walz A, Mazzucchelli L, et al. The C-X-C chemokine ENA-78 is preferentially expressed in intestinal epithelium in inflammatory bowel disease. Gastroenterology 1997;113:808-16. (Pubitemid 27381140)
9. Imada A, Ina K, Shimada M, et al. Coordinate upregulation of interleukin-8 and growth-related gene product-a is present in the colonic mucosa of inflammatory bowel disease. Scand J Gastroenterol 2001; 36:854-64. (Pubitemid 32656561)
10. Keates S, Keates AC, Mizoguchi E, et al. Enterocytes are the primary source of the chemokine ENA-78 in normal colon and ulcerative colitis. Am J Physiol 1997;273:G75-82.
11. Keshavarzian A, Fusunyan RD, Jacyno R, et al. Increased interleukin-8 (IL-8) in rectal dialysate from patients with ulcerative colitis: evidence for a biological role for IL-8 in inflammation of the colon. Am J Gastroenterol 1999;94:704-12. (Pubitemid 29124870)
12. Lauisten K, Laursen LS, Bukhave K, et al. Effects of topical 5-aminosalicylic acid and prednisolone on prostaglandin E2 and leukotriene B4 levels determined by equilibrium in vivo dialysis of rectum in relapsing ulcerative colitis. Gastroenterology 1986;91:837-44. (Pubitemid 16014588)
13. Williams EJ, Haque S, Banks C, et al. Distribution of the interleukin-8 receptors, CXCR1 and CXCR2, in inflamed gut tissue. J Pathol 2000;192:533-9.
14. 2 (CD11b/CD18) independent mechanisms. Clin Exp Immunol 2004;136:262-8. (Pubitemid 38543444)
15. Anton PA, Targan SR, Shanahan F. Increased neutrophil receptors for and response to the proinflammatory bacterial peptide formyl-methionyl- leucyl-phenylalanine in Crohn's disease. Gastroenterology 1989; 97:20-8. (Pubitemid 19190991)
16. Stillie RM, Farooq SM, Gordon JH, et al. The functional significance behind expressing two IL-8 receptor types on PMN. J Leukoc Biol 2009;86:529-43.
17. Carrigan SO, Pink DBS, Stadnyk AW. Neutrophil transepithelial migration in response to the chemoattractant fMLP but not C5a is phospholipase D-dependent and related to the use of CD11b/ CD18. J Leukoc Biol 2007;82:1575-84. (Pubitemid 350276969)
18. Van Den Steen PE,Wuyts A, Husson SJ, et al. Gelatinase B/MMP-9 and neutrophil collagenase/MMP-8 process the chemokines human GCP-2/ CXCL6, ENA-78/CXCL5 and mouse GCP-2/LIX and modulate their physiological activities. Eur J Biochem 2003;270:3739-49. (Pubitemid 37123245)
19. Nufer O, Corbett M,Walz A. Amino-terminal processing of chemokine ENA-78 regulates biological activity. Biochemistry 1999;38:636-42.
20. Haskó G, Cronstein BN. Adenosine: an endogenous regulator of innate immunity. Trend Immunol 2004;25:33-9. (Pubitemid 38032805)
21. Gijsbers K, Van Assche G, Joossens S, et al. CXCR1-binding chemokines in inflammatory bowel diseases: down-regulated IL-8/CXCL8 production by leukocytes in Crohn's disease and selective GCP-2/CXCL6 expression in inflamed intestinal tissue. Eur J Immunol 2004; 34:1992-2000. (Pubitemid 39256080)
22. Nash S, Stafford J, Madara JL. The selective and superoxide-independent disruption of intestinal epithelial tight junctions during leukocyte transmigration. Lab Invest 1988;59:531-7.
23. Siegmund B, Rieder F, Albrich S, et al. Adenosine kinase inhibitor GP515 improves experimental colitis in mice. J Pharmacol Exp Ther 2001;296:99-105. (Pubitemid 32015066)
24. Odashima M, Bamias G, Rivera-Nieves J, et al. Activation of A2A adenosine receptor attenuates intestinal inflammation in animal models of inflammatory bowel diseases. Gastroenterology 2005;129:26-33. (Pubitemid 41002039)
25. Sundaram U, Hassanain H, Suntres Z, et al. Rabbit chronic ileitis leads to up-regulation of adenosine A1/A3 gene products, oxidative stress, and immune modulation. Biochem Pharmacol 2003;65:1529-38. (Pubitemid 36555840)
26. McColl SR, St-Onge M, Dussault AA, et al. Immunomodulatory impact of the A2A adenosine receptor on the profile of chemokines produced by neutrophils. FASEB J 2006;20:187-9. (Pubitemid 43100509)
27. Wollner A,Wollner S, Smith JB. Acting via the A2 receptors, adenosine inhibits the upregulation of Mac-1 (CD11b/CD18) expression on fMLPstimulated neutrophils. Am J Respir Cell Mol Biol 1993;9:179-85.
28. Thiel M, Chambers JD, Chouker A, et al. Effect of adenosine on the expression of beta(2)integrins and L-selectin of human ploymorphonuclear leukocytes in vitro. J Leukoc Biol 1996;59:671-82. (Pubitemid 26198079)
29. Thibault N, Harbour D, Borgeat P, et al. Adenosine receptor occupancy suppresses chemoattractant-induced phospholipase D activity by diminishing membrane recruitment of small GTPases. Blood 2000;95:519-27. (Pubitemid 30041664)
30. Strohmeier GR, Reppert SM, Lencer WI, et al. The A2b adenosine receptor mediates cAMP responses to adenosine receptor agonists in human intestinal epithelia. J Biol Chem 1995;270:2387-94.
31. Sitaraman SV, Merlin D, Wang L, et al. Neutrophil-epithelial crosstalk at the intestinal luminal surface mediated by reciprocal secretion of adenosine and IL-6. J Clin Invest 2001;107:861-9. (Pubitemid 32274039)